retatrutide triple agonist obesity phase 2 trial Eli Lilly's 3 clinical studies investigating retatrutide, the "triple-G" agonist, have found that long-term use can achieve substantial weight loss. Read about the work via the link in the comments phase 2 retatrutide Original Article:

Storage duration for reconstituted peptide solutions depends on the specific peptide, concentration, and storage conditions

The key is to stick with your B12 injection schedule and let it do its thing

*Product may contain benzyl alcohol as an inactive ingredient Contraindications for Benzyl Alcohol This preparation is not advised in patients who are sensitive to cobalt and/or vitamin B12

Tirzepatide and hair loss Tirzepatide provides the most directly comparable data because it was the first dual-agonist to track hair loss in pivotal trials

Sulphur burps (also called sulphurous burps or rotten egg burps) are an unpleasant side effect experienced by some individuals from GLP-1 injections, such as tirzepatide, (Mounjaro) and semaglutide (Wegovy) and tirzepatide, for weight management